Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385777740> ?p ?o ?g. }
- W4385777740 endingPage "123303" @default.
- W4385777740 startingPage "123303" @default.
- W4385777740 abstract "While inhalable nanoparticle-based dry powders have demonstrated promising potential as next-generation respiratory medicines, erratic particle redispersibility and poor manufacturing reproducibility remain major hurdles hindering their translation from bench to bedside. We developed a one-step continuous process for fabricating inhalable remdesivir (RDV) nanoagglomerate dry powder formulations by integrating flash nanoprecipitation and spray drying. The nanosuspension formulation was optimized using a three-factor Box-Behnken design with a z-average particle size of 233.3 ± 2.3 nm and < 20% size change within six hours. The optimized inhalable nanoagglomerate dry powder formulation produced by spray drying showed adequate aqueous redispersibility (Sf/Si = 1.20 ± 0.01) and in vitro aerosol performance (mass median aerodynamic diameter of 3.80 ± 0.58 µm and fine particle fraction of 39.85 ± 10.16%). In A549 cells, RDV nanoparticles redispersed from the inhalable nanoagglomerate powders displayed enhanced and accelerated RDV cell uptake and negligible cytotoxicity at therapeutic RDV concentrations. No statistically significant differences were observed in the critical quality attributes of the inhalable nanoagglomerate powders produced from the continuous manufacturing and standalone batch modes. This work demonstrates the feasibility of large-scale continuous manufacturing of inhalable nanoagglomerate dry powder formulations, which pave the way for their clinical translation." @default.
- W4385777740 created "2023-08-13" @default.
- W4385777740 creator A5017690759 @default.
- W4385777740 creator A5028180779 @default.
- W4385777740 creator A5032134223 @default.
- W4385777740 creator A5080774378 @default.
- W4385777740 creator A5086132807 @default.
- W4385777740 date "2023-09-01" @default.
- W4385777740 modified "2023-10-17" @default.
- W4385777740 title "Integrated continuous manufacturing of inhalable remdesivir nanoagglomerate dry powders: Design, optimization and therapeutic potential for respiratory viral infections" @default.
- W4385777740 cites W1789699122 @default.
- W4385777740 cites W1975132504 @default.
- W4385777740 cites W1976444992 @default.
- W4385777740 cites W1976954322 @default.
- W4385777740 cites W1987964160 @default.
- W4385777740 cites W1998358855 @default.
- W4385777740 cites W2002435315 @default.
- W4385777740 cites W2012882292 @default.
- W4385777740 cites W2026423221 @default.
- W4385777740 cites W2028019892 @default.
- W4385777740 cites W2032941040 @default.
- W4385777740 cites W2034224323 @default.
- W4385777740 cites W2049204300 @default.
- W4385777740 cites W2071037022 @default.
- W4385777740 cites W2077908415 @default.
- W4385777740 cites W2078430129 @default.
- W4385777740 cites W2084157372 @default.
- W4385777740 cites W2089745755 @default.
- W4385777740 cites W2091024871 @default.
- W4385777740 cites W2104808978 @default.
- W4385777740 cites W2109368483 @default.
- W4385777740 cites W2138458345 @default.
- W4385777740 cites W2145434070 @default.
- W4385777740 cites W2153439192 @default.
- W4385777740 cites W2167642476 @default.
- W4385777740 cites W2171527597 @default.
- W4385777740 cites W2328984514 @default.
- W4385777740 cites W2557618066 @default.
- W4385777740 cites W2571125558 @default.
- W4385777740 cites W2611803877 @default.
- W4385777740 cites W2770767649 @default.
- W4385777740 cites W2783618712 @default.
- W4385777740 cites W2789414649 @default.
- W4385777740 cites W2804447614 @default.
- W4385777740 cites W2804601491 @default.
- W4385777740 cites W2883774283 @default.
- W4385777740 cites W2903623629 @default.
- W4385777740 cites W2911318662 @default.
- W4385777740 cites W2931886407 @default.
- W4385777740 cites W2940694051 @default.
- W4385777740 cites W2941157893 @default.
- W4385777740 cites W2949664510 @default.
- W4385777740 cites W2953224333 @default.
- W4385777740 cites W2997180665 @default.
- W4385777740 cites W3007342723 @default.
- W4385777740 cites W3011511289 @default.
- W4385777740 cites W3015619243 @default.
- W4385777740 cites W3040070826 @default.
- W4385777740 cites W3047177224 @default.
- W4385777740 cites W3107680903 @default.
- W4385777740 cites W3126152499 @default.
- W4385777740 cites W3129402209 @default.
- W4385777740 cites W3136539592 @default.
- W4385777740 cites W3138930513 @default.
- W4385777740 cites W3177638556 @default.
- W4385777740 cites W3182972106 @default.
- W4385777740 cites W3208312080 @default.
- W4385777740 cites W3208562227 @default.
- W4385777740 cites W3211887864 @default.
- W4385777740 cites W4200023308 @default.
- W4385777740 cites W4200058053 @default.
- W4385777740 cites W4200206478 @default.
- W4385777740 cites W4206439645 @default.
- W4385777740 cites W4213298567 @default.
- W4385777740 cites W4214845589 @default.
- W4385777740 cites W4229332771 @default.
- W4385777740 cites W4239810836 @default.
- W4385777740 cites W4280526614 @default.
- W4385777740 cites W4282589711 @default.
- W4385777740 cites W4286787625 @default.
- W4385777740 cites W4291669910 @default.
- W4385777740 cites W4294989655 @default.
- W4385777740 cites W4296984362 @default.
- W4385777740 cites W4298626978 @default.
- W4385777740 cites W4319026327 @default.
- W4385777740 cites W4367301840 @default.
- W4385777740 cites W2189043211 @default.
- W4385777740 doi "https://doi.org/10.1016/j.ijpharm.2023.123303" @default.
- W4385777740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37579825" @default.
- W4385777740 hasPublicationYear "2023" @default.
- W4385777740 type Work @default.
- W4385777740 citedByCount "0" @default.
- W4385777740 crossrefType "journal-article" @default.
- W4385777740 hasAuthorship W4385777740A5017690759 @default.
- W4385777740 hasAuthorship W4385777740A5028180779 @default.
- W4385777740 hasAuthorship W4385777740A5032134223 @default.
- W4385777740 hasAuthorship W4385777740A5080774378 @default.
- W4385777740 hasAuthorship W4385777740A5086132807 @default.